Search Results - "Haber, Harry E."

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study by Mancini, G B, Henry, G C, Macaya, C, O'Neill, B J, Pucillo, A L, Carere, R G, Wargovich, T J, Mudra, H, Lüscher, T F, Klibaner, M I, Haber, H E, Uprichard, A C, Pepine, C J, Pitt, B

“…Angiotensin-converting enzyme (ACE) inhibitors may exert some of their benefits in the therapy of hypertension, congestive heart failure, and acute myocardial…”
Get full text

Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor by Nawrocki, James W, Weiss, Stuart R, Davidson, Michael H, Sprecher, Dennis L, Schwartz, Sherwyn L, Lupien, Paul-J, Jones, Peter H, Haber, Harry E, Black, Donald M

“…This 6-week, double-blind clinical trial evaluated lipid parameter responses to different dosages of atorvastatin in patients with primary…”
Get full text

Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial by Pepine, Carl J, Rouleau, Jean-Lucien, Annis, Karen, Ducharme, Anique, Ma, Patrick, Lenis, Jacques, Davies, Richard, Thadani, Udho, Chaitman, Bernard, Haber, Harry E, Freedman, S Ben, Pressler, Milton L, Pitt, Bertram

“…We sought to determine whether angiotensin-converting enzyme inhibition (ACE-I) (i.e., quinapril) prevents transient ischemia (exertional and spontaneous) in…”
Get full text

Effects of Quinapril on Coronary Blood Flow in Coronary Artery Disease Patients With Endothelial Dysfunction by Schlaifer, Jay D, Wargovich, Thomas J, O’Neill, Blair, Mancini, G.B.John, Haber, Harry E, Pitt, Bertram, Pepine, Carl J

“…A study evaluates the effects of quinapril on microvascular endothelial function in patients with mild coronary artery disease and epicardial endothelial…”
Get full text

Influence of smoking status on progression of endothelial dysfunction by Pepine, Carl J., Schlaifer, Jay D., Mancini, G. B. John, Pitt, Bertram, O'Neill, Blair J., Haber, Harry E.

“…Background: Cigarette smoking is a major risk factor for developing coronary artery disease and is associated with increased coronary morbidity and mortality…”
Get full text

Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals by Davidson, Michael H, Naworcki, James W, Weiss, Stuart R, Schwartz, Sherwyn L, Lupien, Paul-J, Jones, Peter H, Haber, Harry E, Black, Donald M

“…Atorvastatin is a highly efficacious hydroxymethylglutaryl-coenzyme A reductase inhibitor that has been shown to reduce low-density lipoprotein cholesterol by…”
Get full text

Effects of angiotensin-converting enzyme inhibition on transient ischemia by Pepine, Carl J., Rouleau, Jean-Lucien, Annis, Karen, Ducharme, Anique, Ma, Patrick, Lenis, Jacques, Davies, Richard, Thadani, Udho, Chaitman, Bernard, Haber, Harry E., Freedman, S.Ben, Pressler, Milton L., Pitt, Bertram

“…We sought to determine whether angiotensin-converting enzyme inhibition (ACE-I) (i.e., quinapril) prevents transient ischemia (exertional and spontaneous) in…”
Get full text

Effects of angiotensin-converting. Enzyme inhibition on transient ischemia: The quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial. Commentary by PEPINE, Carl J, ROULEAU, Jean-Lucien, BEN FREEDMAN, S, PRESSLER, Milton L, PITT, Bertram, ANNIS, Karen, DUCHARME, Anique, MA, Patrick, LENIS, Jacques, DAVIES, Richard, THADANI, Udho, CHAITMAN, Bernard, HABER, Harry E

Get full text

Angiotensin II formation in human vasculature after chronic ACE inhibition : A prospective, randomized, placebo-controlled study by OOSTERGA, M, VOORS, A. A, BUIKEMA, H, PINTO, Y. M, HABER, H. E, EBELS, T, MORSHUIS, W. J, KINGMA, J. H, CRIJNS, H. J. G. M, VAN GILST, W. H

“…The QUO VADIS (the effects of QUinapril On Vascular Ace and Determinants of ISchemia) study was a randomized, double-blind, placebo-controlled trial designed…”
Get full text

Baseline clinical and angiographic data in the quinapril ischemic event (QUIET) Trial by Lees, Robert S., Pitt, Bertram, Chan, Raymond C., Holmvang, Godtfred, Dinsmore, Robert E., Campbell, Lee W., Haber, Harry E., Klibaner, Michael I., Cashin-Hemphill, Linda, The QUIET Investigators

“…The QUinapril Ischemic Event Trial (QUIET) is the first prospective, double-blind, placebo-controlled trial to investigate the long-term antiatherosclerotic…”
Get full text

Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function by SCHLAIFER, J. D, MANCINI, G. B. J, O'NEILL, B. J, PITT, B, HABER, H. E, PEPINE, C. J

“…Our study evaluated the influence of smoking status on coronary endothelial function in normotensive patients with coronary artery disease who received placebo…”
Get full text

Activity of Procanbid®, procainamide twice-daily formulation, to suppress ventricular premature depolarizations by KERIN, N. Z, MEENGS, W. L, TIMMIS, G. C, SALERNO, D, HABER, H. E, SINGER, R. M

Get full text